It is a direct acting inotropic agent whose primary action results from stimulation of the beta-1 receptors of the heart, while producing relatively mild chronotropic effects. In patients with depressed cardiac function, dobutamine increases the stroke volume, and cardiac output without marked increase in heart rate. Systemic vascular resistance is usually reduced with dobutamine. Rarely, however, minimum vasoconstriction has been observed.
Acute heart failure in acute myocardial infarction, cardiogenic shock, following cardias surgery, septic shock. Acute decompensation of chronic CHF, pharmacological stress testing.
Idiopathic hypertrophic subaortic stenosis.
Increased heart rate, blood pressure and ventricular ectopic activity. Hypotension, phlebitis, nausea, headache, nonspecific chest pain, palpitations and shortness of breath.
Patients with a trial fibrillation are at risk of developing rapid ventricular response. Dobutamine may precipitate or exacerbate ventricular ectopic activity. During administration of dobutamine solution, ECG and blood pressure should be continuously monitored. Hypovolemia should be corrected with suitable volume expanders before treatment with dobutamine may cause a marked increase in heart rate or blood pressure, especially systolic pressure. Usually reduction of dosage promptly reverses these effects. In patients who become tolerant to dobutamine while receiving continuous infusions, switching to other drug for several days may allow dobutamine to be reinstituted.
Adults :
Half-life 2 mins.
Shree Ganesh
Pharmaceuticals
|
|||||||||||||||||||||||||||||
|
Disclaimer
:
This guide is provided for information purposes only, and for use
of a registered medical practitioner or a hospital or a laboratory only.
The authors, webmaster, or respective references / links are no way
responsible for the content of the information. Although a concerted
effort has been made to ensure the validity of the information contained
in this document, we give no
assurance for the accuracy of the information in this documents. |